Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00554242 · ClinicalTrials.gov registry record · NA
Effect of Grape Seed Extract Plus Ascorbic Acid on Endothelial Function
A NA study, sponsored by Boston University.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT00554242 is a NA study that has completed, run by Boston University. The registered enrollment target is 40 participants.
The verdict
NCT00554242, a NA study, has completed, sponsored by Boston University.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
A pilot study of 15 subjects will be conducted to confirm an acute effect of grape seed extract on endothelial function. We then will perform a a randomized, double blind, placebo controlled crossover study designed to investigate the benefit of grape seed extract/vitamin C treatment on endothelial function. Participants (n=40) will take a food supplement containing 450 mg of grape seed extract and 1500 mg of vitamin C or matching placebo for four weeks and then cross over to the alternative treatment (active supplement or placebo) for four weeks. We will examine endothelial function before and after each of the two treatment periods. The study will provide information about the vascular effects of these compounds.
Interventions
- DIETARY_SUPPLEMENT Grape seed extract and ascorbic acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2007-07 |
| Est. Completion | 2008-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00554242
The ClinicalTrials.gov registry entry for NCT00554242 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston University, which has 185 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Grape seed extract and ascorbic acid is the first listed.
NCT00554242 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00554242 about?
NCT00554242 is a clinical study titled "Effect of Grape Seed Extract Plus Ascorbic Acid on Endothelial Function". A pilot study of 15 subjects will be conducted to confirm an acute effect of grape seed extract on endothelial function. We then will perform a a randomized, double blind, placebo controlled crossover study designed to investigate the benefit of grape seed extract/vitamin C treatment on endothelial ...
What is the current status of trial NCT00554242?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2007-07. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00554242?
The interventions under investigation include: Grape seed extract and ascorbic acid (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00554242?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.